Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mena

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Investigacion Clinica|June 1, 1995
[Hereditary diseases and congenital malformations at the Unit of Medical Genetics of the University of Zulia. Years: 1983-1992]S González-Ferrer, L Pineda-Del Villar, J Brito-Brito, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinomaL C Scott, J C Yao, A B Benson, et al.
Neuroscience|March 5, 2003
Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's diseaseN Sergeant, A Wattez, M Galván-valencia, et al.
Clinical Genetics|December 17, 2014
A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian GypsiesJ Tenorio, P Navas, E Barrios, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 26, 2024
Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodologyNicholas R Ray, Ajneesh Kumar, Andrew Zaman, et al.
Neurology. Genetics|April 28, 2020
Use of local genetic ancestry to assess <i>TOMM40</i>-523' and risk for Alzheimer diseaseParker L Bussies, Farid Rajabli, Anthony Griswold, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonistsG A Giardina, M Artico, S Cavagnera, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsOlufisayo Oluyinka Elugbadebo, Olusegun Baiyewu, Hephzibah Oyedapo-Ishola, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisPedro R Mena, Andrew F Zaman, Michael L Cuccaro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisLarry D Adams, Jose J Sanchez, Vanessa C Rodriguez, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Investigacion Clinica|June 1, 1995
[Hereditary diseases and congenital malformations at the Unit of Medical Genetics of the University of Zulia. Years: 1983-1992]S González-Ferrer, L Pineda-Del Villar, J Brito-Brito, et al.
Cancer Chemotherapy and Pharmacology|April 10, 2008
A phase II study of pegylated-camptothecin (pegamotecan) in the treatment of locally advanced and metastatic gastric and gastro-oesophageal junction adenocarcinomaL C Scott, J C Yao, A B Benson, et al.
Neuroscience|March 5, 2003
Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's diseaseN Sergeant, A Wattez, M Galván-valencia, et al.
Clinical Genetics|December 17, 2014
A founder EIF2AK4 mutation causes an aggressive form of pulmonary arterial hypertension in Iberian GypsiesJ Tenorio, P Navas, E Barrios, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|August 26, 2024
Disentangling the genetic underpinnings of neuropsychiatric symptoms in Alzheimer's disease in the Alzheimer's Disease Sequencing Project: Study design and methodologyNicholas R Ray, Ajneesh Kumar, Andrew Zaman, et al.
Neurology. Genetics|April 28, 2020
Use of local genetic ancestry to assess <i>TOMM40</i>-523' and risk for Alzheimer diseaseParker L Bussies, Farid Rajabli, Anthony Griswold, et al.
Farmaco (Societa Chimica Italiana : 1989)|August 12, 1999
Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonistsG A Giardina, M Artico, S Cavagnera, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsOlufisayo Oluyinka Elugbadebo, Olusegun Baiyewu, Hephzibah Oyedapo-Ishola, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisPedro R Mena, Andrew F Zaman, Michael L Cuccaro, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisLarry D Adams, Jose J Sanchez, Vanessa C Rodriguez, et al.
Pageof 11